Assertion: imp | /r/MadeOf | available
Facets:
value: for use in the trial
type: PURPOSE
value: to the investigator
type: TRANSITIVE-OBJECT
Source sentences:
text: In addition to QP certification in the listed country, the clinical trial is authorised by the MHRA before IMP is made available to the Investigator
text: Regulatory release of the IMP may be given for some countries at different times therefore the Sponsor should ensure the regulatory release is in place for the UK prior to IMP being made available for use in the trial.